Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy

Postoperative recurrence of gastric cancer depends on whether the chemotherapy cycle was more than 9 cycles

(2022) Yifan Li et al.   MEDICINE

Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9

(2022) Yifan Li et al.   Frontiers in Surgery

Appropriate Number of Adjuvant Chemotherapy Cycles for Patients with Stage 2 or 3 Gastric Cancer After Curative Gastrectomy: A Multicenter Cohort Study

(2021) Sang-Ho Jeong et al.   ANNALS OF SURGICAL ONCOLOGY

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?

(2021) Qichen Chen et al.   Annals of Translational Medicine

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials

(2021) Akira Tsuburaya et al.   Gastric Cancer

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer

(2021) David D'Andrea et al.   JOURNAL OF UROLOGY

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

(2021) Feng‐Hua Wang et al.   Cancer Communications

Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study

(2019) Yi-Hung Kuo et al.   BMC CANCER

Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey

(2019) Maria Westerhoff et al.   MODERN PATHOLOGY

Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy

(2015) Kohei Shitara et al.   Gastric Cancer

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

(2010) Ilfet Songun et al.   LANCET ONCOLOGY